TMEDT. Rowe Price Health Care ETF

Grow my money1y track recordRanked #2,244 of 2,966 in this goal

Seeks long-term capital appreciation.

By T. Rowe Price · Launched 2025

Annual Cost

0.44%

#2,165 of 5,568 · average

Fund Size

$21M

#4,344 of 5,568 · small

Return (1Y)Goal

+27.8%

Track Record

1 year

#4,457 of 5,568 · young

Performance

Total-return NAV · USD

Growth of $10,000

$12,998+30.0%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Cap

Multi cap

Strategy

Active selection

Factor

Multifactor

Sector

Health care

Focus

Biotech & Genomics

Index tracked

MSCI GICS Health Care sector

What it actually holds

By weight

Concentration

Top 10 holdings = 50.0% of fundmoderately concentrated

ELI LILLY & CO

14.8%

UNITEDHEALTH GROUP INC

7.3%

ABBOTT LABORATORIES

4.6%

GILEAD SCIENCES INC

3.9%

INTUITIVE SURGICAL INC

3.7%

ABBVIE INC

3.7%

THERMO FISHER SCIENTIFIC INC

3.7%

DANAHER CORP

3.1%

BECTON DICKINSON AND CO

2.6%

CYTOKINETICS INC

2.5%

Asset allocation

Stocks

99.8%

Cash

0.3%

By sector

Healthcare

100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

18.2%Moderate

Year-on-year price swings

Max drawdown

-11.1%Mild

Worst peak-to-trough loss

Sharpe (3Y)

Unavailable

Needs 3+ years of history

Sortino (3Y)

Not yet

Needs 3+ years of history

Where to buy

Listing

Exchange: NASDAQ Global Select Market

Full fund details

Objective: Seeks long-term capital appreciation.
Strategy: Invests primarily in health care companies, defined as those engaged in health care innovations, pharmaceuticals, biotechnology, and related sectors. Uses fundamental analysis and may invest in U.S. and foreign stocks across all market capitalizations.
Inception date: June 11, 2025
Fund family: T. Rowe Price